In a female patient with thyrotoxicosis on atenolol, where should a blind lumbar epidural blood patch be placed when no cerebrospinal fluid leak is detected?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blind Epidural Blood Patch Placement When No CSF Leak is Detected

When no cerebrospinal fluid leak is detected on imaging, a non-targeted (blind) epidural blood patch should be placed at the lumbar level, typically at L3-4, using high-volume injection (up to two attempts may be considered). 1

Recommended Approach

Primary Placement Site

  • Lumbar epidural space (L3-4 level) is the standard location for blind/non-targeted epidural blood patches 2
  • This is recommended regardless of where the suspected leak might be located
  • High-volume blood injection should be used to maximize epidural spread

Clinical Context

The 2023 multidisciplinary consensus guidelines specifically address this scenario when patients have:

  • High clinical suspicion of spontaneous intracranial hypotension (SIH)
  • Normal brain and spine MRI (no leak identified)
  • Failed conservative management

In these cases, up to two high-volume non-targeted lumbar EBPs could be considered before proceeding to more invasive myelography 1

Post-Procedure Positioning

Critical positioning detail: After a non-targeted blood patch, the patient should be placed in either:

  • Supine position, OR
  • Trendelenburg position (head down)

This positioning for 30 minutes to 2-24 hours facilitates rostral (upward) blood flow through the epidural space, allowing the injected blood to reach potential leak sites higher in the spine through the negative pressure gradient 1, 3, 4

Evidence Quality Considerations

Why Lumbar Over Other Sites?

Research comparing blind patch locations shows:

  • Cervicothoracic blind patches (T4-6 level) have been attempted in some cases 5
  • However, lumbar approach remains standard because blood can migrate rostrally through the epidural space to reach cervical/thoracic leaks 3, 4
  • One study showed 52% success rate with blind lumbar EBP versus 87.1% with targeted patches 2

Efficacy Limitations

Important caveat: Blind patches are significantly less effective than targeted patches when a leak site can be identified:

  • Blind lumbar EBP: 52-70.8% complete recovery 2, 6
  • Targeted EBP: 87.1-90.9% complete recovery 2, 6
  • Patients with unidentified leaks often require repeat blood patches 6

When to Escalate

If 1-2 blind lumbar blood patches fail to provide sustained relief, the guidelines recommend:

  1. Myelography (CT myelography or digital subtraction myelography) to identify the leak site 1
  2. Targeted blood patch once leak is localized
  3. Consider referral to specialist center with multidisciplinary team 1

Special Consideration for Your Patient

Regarding the atenolol/thyrotoxicosis: Beta-blockers mask tachycardia in hyperthyroidism, and abrupt withdrawal could precipitate thyroid storm 7. Continue atenolol through the blood patch procedure—there is no contraindication to EBP in patients on beta-blockers. Monitor for bradycardia during the procedure as standard practice 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.